IL-6,IL-1β及TNF-α与大鼠骨质疏松形成的关系

被引:49
作者
邱奕雁
朱峰
蓝涛
陈扬
杨欣建
机构
[1] 深圳市第二人民医院/深圳大学第一附属医院脊柱外科
关键词
IL-1β; IL-6; TNF-α; 大鼠; 骨质疏松; 关系;
D O I
10.13241/j.cnki.pmb.2016.18.012
中图分类号
R580 [];
学科分类号
摘要
目的:研究白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)及肿瘤坏死因子-α(TNF-α)与大鼠骨质疏松形成的关系,为研究细胞因子与骨质疏松之间的相关作用机制提供参考。方法:选择2015年1月至2015年11月我院采购的90只雌性大鼠作为研究对象,按照数字随机法将大鼠分成观察组(n=45)以及对照组(n=45)。观察组制成骨质疏松模型,对照组不作处理,对比两组局部骨密度,成骨细胞,骨小梁以及破骨细胞在视野面积中的比例,骨组织相关细胞因子水平,分析IL-6、IL-1β以及TNF-α水平与大鼠骨质疏松的相关性。结果:观察组椎体骨密度(BD)和椎间盘BD以及小关节BD均明显低于对照组,差异均有统计学意义(P<0.05);观察组骨小梁和成骨细胞在视野面积中的比例明显低于对照组,而破骨细胞在视野面积中的比例明显高于对照组,差异均有统计学意义(P<0.05);观察组IL-6和IL-1β以及TNF-α均明显高于对照组,差异有统计学意义(P<0.05)。IL-6、IL-1β以及TNF-α水平与大鼠椎体BD、椎间盘BD以及小关节BD均呈明显负相关。结论:去卵巢大鼠的细胞因子与其骨质疏松具有紧密联系,表现在IL-6、IL-1β以及TNF-α水平与大鼠椎体BD、椎间盘BD以及小关节BD均呈明显负相关。
引用
收藏
页码:3448 / 3451
页数:4
相关论文
共 10 条
[1]
锦州市225名老年人骨质疏松相关症状及危险因素的调查分析 [J].
侯璇 ;
吴巧凤 ;
金炜婷 ;
刘堃 .
辽宁医学院学报, 2014, 35 (05) :68-70
[2]
Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation [J].
Uchino, Kaho ;
Okamoto, Kuniaki ;
Sakai, Eiko ;
Yoneshima, Erika ;
Iwatake, Mayumi ;
Fukuma, Yutaka ;
Nishishita, Kazuhisa ;
Tsukuba, Takayuki .
PHYTOTHERAPY RESEARCH, 2015, 29 (11) :1714-1721
[3]
Neutrophil–lymphocyte ratio is associated with arterial stiffness in postmenopausal women with osteoporosis.[J].Xin-yang Yu;Xue-song Li;Ying Li;Tiemin Liu;Rui-tao Wang.Archives of Gerontology and Geriatrics.2015, 1
[4]
Mollugin from Rubea cordifolia suppresses receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorbing activity in vitro and prevents lipopolysaccharide-induced bone loss in vivo [J].
Baek, Jong Min ;
Kim, Ju-Young ;
Jung, Youngeun ;
Moon, Seong-Hee ;
Choi, Min Kyu ;
Kim, Seong Hwan ;
Lee, Myeung Su ;
Kim, Ikyon ;
Oh, Jaemin .
PHYTOMEDICINE, 2015, 22 (01) :27-35
[5]
Effect of serum from postmenopausal women with osteoporosis exhibitingthe Kidney‑Yang deficiency pattern on bone formation in an hFOB 1.19 human osteoblasticcell line.[J].Yachan Li;Wenna Liang;Xihai Li;Bizhen Gao;Huijuan Gan;Lianhua Yin;Jianying Shen;Jie Kang;Shanshan Ding;Xuejuan Lin;Linghong Liao;Candong Li.Experimental and Therapeutic Medicine.2015, 3
[6]
microRNA-210 is involved in the regulation of postmenopausal osteoporosis through promotion of VEGF expression and osteoblast differentiation [J].
Liu, Xiao-Dong ;
Cai, Feng ;
Liu, Liang ;
Zhang, Yan ;
Yang, An-Li .
BIOLOGICAL CHEMISTRY, 2015, 396 (04) :339-347
[7]
The Anti-Osteoporosis and Antioxidant Activities of Chemical Constituents from Chrysanthemum indicum Flowers [J].
Bui Thi Thuy Luyen ;
Bui Huu Tai ;
Nguyen Phuong Thao ;
Lee, Young Mi ;
Lee, Sang Hyun ;
Jang, Hae Dong ;
Kim, Young Ho .
PHYTOTHERAPY RESEARCH, 2015, 29 (04) :540-548
[8]
Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis [J].
Zhang, Jing ;
Fu, Qin ;
Ren, Zhaozhou ;
Wang, Yanjun ;
Wang, Chenchen ;
Shen, Tao ;
Wang, Guangbin ;
Wu, Lina .
GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (03) :183-190
[9]
Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.[J].Yusuke Kameda;Masahiko Takahata;Shintaro Mikuni;Tomohiro Shimizu;Hiroki Hamano;Takashi Angata;Shigetsugu Hatakeyama;Masataka Kinjo;Norimasa Iwasaki.Bone.2015,
[10]
The role of MicroRNAs in Osteoclasts and Osteoporosis [J].
Tang, Peifu ;
Xiong, Qi ;
Ge, Wei ;
Zhang, Lihai .
RNA BIOLOGY, 2014, 11 (11) :1355-1363